[1] |
Rabe KF,Watz H.Chronic obstructive pulmonary disease[J].Lancet,2017,389(10082):1931-1940.
|
[2] |
ThunMJ,CarterBD,FeskanichD,etal.50-Yeartrendsinsmoking-related mortality in the United States[J].N Engl J Med,2013,368(4):351-364.
|
[3] |
Degens H,Gayan-Ramirez G,van Hees HW.Smoking-induced skeletal muscle dysfunction.From evidence to mechanisms[J].Am J Respir Crit Care Med,2015,191(6):620-625.
|
[4] |
ZuoL,NogueiraL,HoganMC.EffectofpulmonaryTNF-α overexpression on mouse isolated skeletal muscle function[J].Am J Physiol Regul Integr Comp Physiol,2011,301(4):1025-1031.
|
[5] |
Su Y,Cao W,Han Z,et al.Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells:the role of calpain[J].Am J Physiol Lung Cell Mol Physiol,2004,287(4):794-800.
|
[6] |
Adnan M,Morton G,Hadi S.Analysis of rpoS and bolA gene expression under various stress-induced environments in planktonic and biofilm phase using 2-ΔΔCTmethod[J].Mol Cell Biochem,2011,357(1-2):275-282.
|
[7] |
Adeloye D,Chua S,Lee C,et al.Global and regional estimates of COPD prevalence:systematic review and meta-analysis[J].J Global Health,2015,5(2):020415.
|
[8] |
Collaborators MCOD.Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2015,385(9963):117-171.
|
[9] |
Yang G,Wang Y,Zeng Y,et al.Rapid health transition in China,1990-2010:findings from the Global Burden of Disease Study 2010[J].Lancet,2013,381(9882):1987.
|
[10] |
张荣葆,谭星宇,何权瀛.从流行病学调查结果看我国慢性阻塞性肺疾病诊断不足问题[J].中华健康管理学杂志,2013,7(1):44-47.
|
[11] |
Pires-Yfantouda R,Absalom G,Clemens F.Smoking cessation interventions for COPD:a review of the literature[J].Respir Care,2013,58(11):1955-1962.
|
[12] |
Kok MO,Hoekstra T,Twisk JW.The longitudinal relation between smoking and muscle strength in healthy adults[J].Eur Addict Res,2012,18(2):70-75.
|
[13] |
Decramer M,Janssens W.Chronic obstructive pulmonary disease and comorbidities[J].Chron Respir Dis,2012,9(3):183-191.
|
[14] |
Hayot M,Rodriguez J,Vernus B,et al.Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli[J].Mol Cell Endocrinol,2011,332(1-2):38-47.
|
[18] |
Jackman RW,Kandarian SC.The molecular basis of skeletal muscle atrophy[J].Am J Physiol Cell Physiol,2004,287(4):834-843.
|
[15] |
Rom O,Kaisari S,Aizenbud D,et al.Identification of possible cigarette smoke constituents responsible for muscle catabolism[J].J Muscle Res Cell Motil,2012,33(3-4):199-208.
|
[16] |
Degens H.The role of systemic inflammation in age-related muscle weakness and wasting[J].Scand J Med Sci Sports,2010,20(1):28-38.
|
[17] |
Liu Q,Xu WG,Luo Y,et al.Cigarette smoke-induced skeletal muscle atrophy is associated with up-regulation of USP-19 via p38 and ERK MAPKs[J].J Cell Biochem,2011,112(9):2307-2316.
|
[19] |
Caron MA,Morissette MC,Thériault ME,et al.Alterations in skeletal muscle cell homeostasis in a mouse model of cigarette smoke exposure[J].PLoS One,2013,8(6):e66433.
|
[20] |
Remels AH,Gosker HR,Vander V,et al.Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease:state of the art and novel insights in regulation of muscle plasticity[J].Clin Chest Med,2007,28(3):537-552.
|